Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
about
Atrial fibrillation in heart failure: what should we do?Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis.Data quality evaluation for observational multiple sclerosis registries.Signal detection activity on EudraVigilance data: analysis of the procedure and findings from an Italian Regional Centre for Pharmacovigilance.Patient-Reported Outcomes for Quality of Life Assessment in Atrial Fibrillation: A Systematic Review of Measurement PropertiesClinical characteristics and prognostic impact of atrial fibrillation in patients with chronic heart failure.Increased All-Cause Mortality Associated With Digoxin Therapy in Patients With Atrial Fibrillation: An Updated Meta-Analysis.Digoxin versus placebo, no intervention, or other medical interventions for atrial fibrillation and atrial flutter: a protocol for a systematic review with meta-analysis and Trial Sequential Analysis.Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF-TIMI 48 TrialA review of rate control in atrial fibrillation, and the rationale and protocol for the RATE-AF trial.Is echocardiography valid and reproducible in patients with atrial fibrillation? A systematic review.The treatment gap in patients with chronic systolic heart failure: a systematic review of evidence-based prescribing in practice.Contemporary Controversies in Digoxin Use in Systolic Heart Failure.Pharmacogenomics of heart failure: a systematic review.Potentially inappropriate medications: predictor for mortality in a cohort of community-dwelling older adults.Assumption versus evidence: the case of digoxin in atrial fibrillation and heart failure.The intensive care medicine research agenda on septic shock.Rationales and choices for the treatment of patients with NYHA class II heart failure.Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management.Istaroxime, a potential anticancer drug in prostate cancer, exerts beneficial functional effects in healthy and diseased human myocardium.Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality.Digoxin and mortality: lessons for observational studies.Venous-to-arterial carbon dioxide difference: an experimental model or a bedside clinical tool?Digoxin Is Associated With Increased Shock Events and Electrical Storms in Patients With Implantable Cardioverter Defibrillators.Observational research rigour alone does not justify causal inference.Digoxin and Amiodarone on the Risk of Ischemic Stroke in Atrial Fibrillation: An Observational Study.In-hospital major arrhythmias, arrhythmic death and resuscitation after successful primary percutaneous intervention for acute transmural infarction: a retrospective single-centre cohort study.Primary versus secondary source of data in observational studies and heterogeneity in meta-analyses of drug effects: a survey of major medical journals
P2860
Q26784426-01815BFC-A0B0-49CF-BEF4-D781AA800D00Q30240765-1C15B58B-82E9-42F9-B393-1B473EE64D02Q31119031-81CD8D8D-86E8-411E-8CA7-D4C88533A683Q31155016-1514DB6D-55B2-4C99-AC31-D3833FE455C5Q36179407-D9E145F3-B99F-4090-ABE2-349F736B6614Q37443847-AAEACAC0-DE61-4E5E-9476-DEEEF4E3AA6AQ37624266-18195D25-D5C8-43EB-8BEF-D379672ABE67Q37739398-07C36FBF-87BD-4D3D-B70B-D2954F315DF7Q38374710-890B1C17-0139-4C55-879C-38DD2FB3B38FQ38654100-F539707E-3014-4651-B311-9B97D1B792E8Q38848144-3B29412F-A3F2-47F6-8B4A-09A4D83218B8Q38910426-2749D9FD-2F32-462E-9DC0-4FD3DBEB684AQ38970521-0665DDDB-FCC6-4A03-A8C3-61E296D72039Q38998634-BCC2EDBE-9E72-4553-AA23-666D37A89224Q39008761-8B80F267-8110-447E-9820-3DC316E13B7AQ39075410-35920570-E5BC-44F5-8236-146A47284586Q39303486-72B728CE-8EAF-489D-AA5E-67DA5920AF5CQ39410727-84D55730-0FF3-4162-B357-DAEE981954A8Q39445718-AF3EC178-36CC-428D-AFB8-D202A9335566Q41472411-4AA13470-76DC-404D-A288-CB45A98955E4Q42673198-27D91288-5BE7-42E1-8E5F-3ECD354E8453Q43113878-19EB861B-5829-4753-930E-BB4ACB240E98Q47614330-36CE13CD-B2A4-4373-9814-9BFBD8D95D79Q47648452-6EF7E7E6-706E-4802-B336-54B3A486E718Q49427362-6A343F9A-19A3-41FF-8A5D-AF325DAD3C6BQ55280835-678B688D-574F-4BDE-B2E5-B5E2D47B99A2Q55466898-3F47DAFA-951F-4759-9B04-CB2D8FA33D99Q59128777-8DB08600-611A-49EA-ADF5-BE29C4A61AD2
P2860
Safety and efficacy of digoxin: systematic review and meta-analysis of observational and controlled trial data
description
2015 nî lūn-bûn
@nan
2015 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Safety and efficacy of digoxin ...... onal and controlled trial data
@ast
Safety and efficacy of digoxin ...... onal and controlled trial data
@en
Safety and efficacy of digoxin ...... onal and controlled trial data
@nl
type
label
Safety and efficacy of digoxin ...... onal and controlled trial data
@ast
Safety and efficacy of digoxin ...... onal and controlled trial data
@en
Safety and efficacy of digoxin ...... onal and controlled trial data
@nl
prefLabel
Safety and efficacy of digoxin ...... onal and controlled trial data
@ast
Safety and efficacy of digoxin ...... onal and controlled trial data
@en
Safety and efficacy of digoxin ...... onal and controlled trial data
@nl
P2093
P2860
P31
P50
P921
P3181
P356
P1433
P1476
Safety and efficacy of digoxin ...... onal and controlled trial data
@en
P2093
Deirdre A Lane
Gregory Y H Lip
Michael Griffith
Monica Samra
P2860
P3181
P356
10.1136/BMJ.H4451
P407
P5008
P577
2015-08-30T00:00:00Z